Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel-Reference-Cited by-同舟云学术

Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel

Published:2016-10 Issue:10 Volume:4 Page:850-861
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Santos Raul D,Gidding Samuel S,Hegele Robert A,Cuchel Marina A,Barter Philip J,Watts Gerald F,Baum Seth J,Catapano Alberico L,Chapman M John,Defesche Joep C,Folco Emanuela,Freiberger Tomas,Genest Jacques,Hovingh G Kees,Harada-Shiba Mariko,Humphries Steve E,Jackson Ann S,Mata Pedro,Moriarty Patrick M,Raal Frederick J,Al-Rasadi Khalid,Ray Kausik K,Reiner Zelijko,Sijbrands Eric J G,Yamashita Shizuya

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference94 articles.

1. The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association;Gidding;Circulation,2015

2. Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication;Benn;J Clin Endocrinol Metab,2012

3. Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation;Watts;J Clin Lipidol,2014

4. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management—a position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society;Cuchel;Eur Heart J,2014

5. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society;Nordestgaard;Eur Heart J,2013

Cited by 353 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study;The Lancet Diabetes & Endocrinology;2024-09

2. Recent progress in gene therapy for familial hypercholesterolemia treatment;iScience;2024-09

3. The therapeutic effect of liver transplantation in 14 children with homozygous familial hypercholesterolemia: a prospective cohort;Journal of Clinical Lipidology;2024-09

4. A Rapid and Scalable Multiplex PCR-Based Next-Generation Amplicon Sequencing Method for Familial Hypercholesterolemia Genetic Screening;The Journal of Applied Laboratory Medicine;2024-08-14

5. Genetic testing for familial hypercholesterolemia: a review of the current state of its implementation in Canada;CJC Open;2024-08